Systemic adiponectin levels in colorectal cancer and adenoma: a systematic review and meta-analysis.
Anne MacleodKatharina M ScheurlenJames F BurtonMary Alex ParksMst Sharmin Akter SumyJeremy T GaskinsSusan GalandiukPublished in: International journal of obesity (2005) (2023)
Studies suggest a trend towards lower systemic adiponectin levels in colorectal cancer patients, but the heterogeneity observed showed current evidence is not sufficient to definitively draw any conclusions. These data, however, suggest rising adiponectin is unlikely to account for the reported observation of increased CRC following bariatric surgery. Further studies with prospective age, race, and BMI-matched cohorts, and standardized adiponectin measurements may provide a better understanding of this relationship.